A NephJC short on the latest baxdrostat trial
Finerenone Finally Finishing off Spironolactone?
Aldosterone Synthase Inhibitors in Proteinuric CKD: the Visual Abstract
Yet another new medication class for use in the RAAS cascade. BI 690517, an aldosterone synthase inhibitor, has been shown to significantly reduce proteinuria with or without empagliflozin. VA by Brian Rifkin.
